Episode 377: GLP-1 Anti-Obesity Medications Update-Efficacy, Muscle Risk, and Future

Play this episode

About this episode

Episode Summary: The Cardiometabolic Revolution of Semaglutide, Tirzepatide, and BeyondThis episode provides a comprehensive, evidence-based update on GLP-1 receptor agonists (anti-obesity medications), featuring Dr. Jordan Feigenbaum, Dr. Austin Baraki, and Dr. Spencer Nadolsky. The hosts review the rapid evolution of these drugs—from short-acting injectables to potent multi-agonists like Tirzepatide (Mounjaro/Zepbound) and Retatrutide—which now achieve weight loss efficacy rivaling bariatric s

Listen anywhere